Fused phenylalanine derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Details for Australian Patent Application No. 2004286857 (hide)

Owner Merck & Co., Inc.

Inventors Dong, Hong; Ashton, Wallace T.; Xu, Jinyou

Agent Spruson & Ferguson

Pub. Number AU-A-2004286857

PCT Pub. Number WO2005/044195

Priority 60/517,287 04.11.03 US

Filing date 29 October 2004

Wipo publication date 19 May 2005

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/044195 Priority application(s): WO2005/044195

14 May 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004286865-Toothbrush employing an acoustic waveguide

2004286855-Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof